BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tosh DK, Salmaso V, Rao H, Campbell R, Bitant A, Gao ZG, Auchampach JA, Jacobson KA. Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists. ACS Med Chem Lett 2020;11:1935-41. [PMID: 33062176 DOI: 10.1021/acsmedchemlett.9b00637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Suresh RR, Gao ZG, Salmaso V, Chen E, Campbell RG, Poe RB, Liston TE, Jacobson KA. Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. ACS Med Chem Lett 2022;13:623-31. [PMID: 35450351 DOI: 10.1021/acsmedchemlett.1c00685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Farr SA, Cuzzocrea S, Esposito E, Campolo M, Niehoff ML, Doyle TM, Salvemini D. Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury. J Neuroinflammation 2020;17:339. [PMID: 33183330 DOI: 10.1186/s12974-020-02009-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Wen Z, Salmaso V, Jung YH, Phung NB, Gopinatth V, Shah Q, Patterson AT, Randle JCR, Chen Z, Salvemini D, Lieberman DI, Whitehead GS, Karcz TP, Cook DN, Jacobson KA. Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist. J Med Chem 2022. [PMID: 35113556 DOI: 10.1021/acs.jmedchem.1c01964] [Reference Citation Analysis]
4 Maryanoff BE, Wipf P. Presenting a Special Issue on "Medicinal Chemistry: From Targets to Therapies". ACS Med Chem Lett 2020;11:1780-2. [PMID: 33062151 DOI: 10.1021/acsmedchemlett.0c00508] [Reference Citation Analysis]
5 Salmaso V, Jain S, Jacobson KA. Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization. Methods Cell Biol 2021;166:133-59. [PMID: 34752329 DOI: 10.1016/bs.mcb.2021.06.001] [Reference Citation Analysis]
6 Salmaso V, Jacobson KA. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design. ChemMedChem 2020;15:1958-73. [PMID: 32803849 DOI: 10.1002/cmdc.202000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jacobson KA, Salmaso V, Suresh RR, Tosh DK. Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. RSC Med Chem 2021;12:1808-25. [PMID: 34825182 DOI: 10.1039/d1md00167a] [Reference Citation Analysis]
8 Scortichini M, Idris RM, Moschütz S, Keim A, Salmaso V, Dobelmann C, Oliva P, Losenkova K, Irjala H, Vaittinen S, Sandholm J, Yegutkin GG, Sträter N, Junker A, Müller CE, Jacobson KA. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors. J Med Chem 2022. [PMID: 35080883 DOI: 10.1021/acs.jmedchem.1c01852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Abel B, Murakami M, Tosh DK, Yu J, Lusvarghi S, Campbell RG, Gao Z, Jacobson KA, Ambudkar SV. Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2. European Journal of Medicinal Chemistry 2022;231:114103. [DOI: 10.1016/j.ejmech.2022.114103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tosh DK, Salmaso V, Campbell RG, Rao H, Bitant A, Pottie E, Stove CP, Liu N, Gavrilova O, Gao ZG, Auchampach JA, Jacobson KA. A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity. Eur J Med Chem 2022;228:113983. [PMID: 34844790 DOI: 10.1016/j.ejmech.2021.113983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]